Eric Kaldjian
Principal investigator, leads RARECYTE, INC..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$2.5MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 9, 2021 | NIH | SBIR Phase II Rapid highly multi-plexed immuno-profiling of solid tumors by SpectralEdge imaging | $848K | RARECYTE, INC. |
| Sep 9, 2020 | NIH | SBIR Phase II Rapid highly multi-plexed immuno-profiling of solid tumors by SpectralEdge imaging | $1.1M | RARECYTE, INC. |
| Mar 20, 2018 | NIH | STTR Phase I Highly Multiplexed Analysis of Solid Tumors and Liquid Tissues by Cyclic Immunofluorescence | $224K | RARECYTE, INC. |
| Jul 15, 2015 | NIH | SBIR Phase I Direct visualization assay for detection of B. burgdorferi in early Lyme Disease | $299K | RARECYTE, INC. |
Peer ranks
Federal funding#850
Awards as PI#643
Patents#505
Companies
- RARECYTE, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.